Cancer is staged by measuring three things: how large the tumor is, whether it has reached nearby lymph nodes, and whether it has spread to distant parts of the body. These three factors are combined into an overall stage, numbered 0 through IV, with higher numbers indicating more advanced disease. Staging shapes nearly every decision that follows, from treatment options to survival estimates.
The TNM System
Most solid tumors are staged using the TNM system, maintained by the American Joint Committee on Cancer (AJCC). Each letter captures a different dimension of the cancer’s extent:
- T (Tumor): The size of the primary tumor and whether it has grown into nearby tissue. A T1 tumor is smaller and more contained than a T3 or T4.
- N (Nodes): Whether cancer cells have reached nearby lymph nodes, the small immune-system filters scattered throughout the body. N0 means no lymph node involvement; higher numbers mean more nodes are affected.
- M (Metastasis): Whether the cancer has spread to distant organs. M0 means it hasn’t. M1 means it has.
Each category gets a number, producing a combination like T2N1M0. That combination is then translated into one of the broader stage groupings most people are familiar with.
What Stages 0 Through IV Mean
The TNM combinations map onto five overall stages. These give a quick picture of how advanced the cancer is.
Stage 0 describes abnormal cells that haven’t spread into surrounding tissue. This is sometimes called carcinoma in situ. It isn’t technically cancer yet, but it can become cancer if left untreated.
Stages I, II, and III confirm that cancer is present. The higher the number, the larger the tumor and the more it has spread into nearby tissues or lymph nodes. A stage I breast cancer, for example, is small and localized, while a stage III breast cancer may have grown into the chest wall or involved many lymph nodes, but it still hasn’t spread to distant organs.
Stage IV means the cancer has spread to distant parts of the body. This is what most people mean when they say a cancer has metastasized. Common sites of distant spread vary by cancer type but include the lungs, liver, bones, and brain.
How Doctors Gather Staging Information
Staging isn’t a single test. It’s built from a combination of imaging, biopsies, and sometimes surgery.
Imaging provides the map. CT scans produce three-dimensional slices of the body and can reveal tumor size, depth, and whether masses appear in other organs. MRI is sometimes more sensitive than CT for distinguishing soft tissues, making it especially useful for brain, spinal, and pelvic cancers. PET scans detect areas of unusually high metabolic activity, which can flag cancer that has spread to places too small to see on a CT alone. Ultrasound plays a supporting role, particularly for tumors near the body’s surface or in organs like the liver and thyroid.
Because tumors can be tiny and deep within the body, doctors typically rely on CT, MRI, or PET (or some combination) to identify suspected areas of spread. No single scan does everything. A CT might show a suspicious spot in the lung, and a PET scan can help clarify whether that spot is active cancer or something harmless like scar tissue.
The Role of Biopsies
Imaging shows where cancer might be, but a biopsy confirms it. A tissue sample is removed and examined under a microscope to verify whether cancer cells are present.
One particularly important biopsy technique is the sentinel lymph node biopsy. The sentinel node is the first lymph node that fluid drains to from the area around a tumor, making it the most likely first stop for spreading cancer cells. During the procedure, a surgeon identifies this node (using a dye or a small amount of radioactive tracer), removes it, and sends it to a pathologist. If no cancer is found, the patient can often avoid having many lymph nodes removed, which reduces the risk of complications like chronic swelling. If cancer is found, additional nodes may need to come out, and the staging is adjusted upward. This technique is most commonly used in breast cancer and melanoma.
Clinical Staging vs. Pathological Staging
Staging happens at two different points, and the results don’t always match. Clinical staging is the initial estimate, based on physical exams, imaging, and any biopsies done before treatment. It’s the best picture doctors can assemble without surgery.
Pathological staging comes after surgery, when a pathologist examines the removed tumor and any lymph nodes under a microscope. This is generally more accurate because it reveals details that imaging can miss, like microscopic clusters of cancer cells in a lymph node that looked clean on a scan. In medical records, clinical stage is often noted with a lowercase “c” (cT2N0M0), while pathological stage uses a “p” (pT2N1M0).
Not every patient gets pathological staging. If surgery isn’t part of the treatment plan, clinical staging is what guides decisions.
Grade vs. Stage
Stage and grade are often confused, but they measure different things. Stage describes how far the cancer has spread. Grade describes how abnormal the cancer cells look under a microscope compared to healthy cells.
Low-grade cancer cells still resemble normal tissue and tend to grow more slowly. High-grade cells look very different from normal tissue (pathologists call them “poorly differentiated” or “undifferentiated”) and tend to be more aggressive. Two patients with the same stage cancer can have very different outlooks if one tumor is low grade and the other is high grade. Both factors feed into treatment planning.
How Blood Cancers Are Staged
The TNM system works for solid tumors, the kind that form a mass you could theoretically measure. Blood cancers like leukemia and lymphoma don’t behave that way. They circulate through the bloodstream and lymphatic system from the start, so they need different frameworks.
Lymphomas are staged using the Lugano classification, a modified version of the older Ann Arbor system. It focuses on how many groups of lymph nodes are involved and whether the disease is on one side or both sides of the diaphragm (the muscle separating your chest from your abdomen), plus whether organs outside the lymph system are affected.
Chronic lymphocytic leukemia, one of the most common adult leukemias, uses the Rai system in the United States and the Binet system in Europe. These systems classify disease based on factors like blood cell counts, lymph node enlargement, and whether the spleen or liver is involved, rather than tumor size. Some blood cancers, like hairy cell leukemia, have no standard staging system at all because treatment decisions rely more on symptoms and blood test results than on a formal stage number.
Why Staging Matters for Treatment
The stage at diagnosis is the single most important factor in determining treatment options. An early-stage cancer may need only surgery, while the same cancer at a later stage might require a combination of surgery, radiation, and systemic therapy. Stage also determines eligibility for clinical trials, which often enroll patients at specific stages.
One important detail: staging is typically set at the time of diagnosis and doesn’t change, even if the cancer progresses later. If a stage II colon cancer eventually spreads to the liver, it’s still referred to as stage II colon cancer with liver metastasis, not stage IV colon cancer. This convention exists so that survival statistics remain comparable across patients. Doctors may “restage” the cancer to describe its current extent, but the original stage stays in the medical record as a reference point.